Close Menu

NEW YORK (GenomeWeb) – OpGen reported after the close of the market Tuesday that its fourth quarter revenues fell 23 percent year over year.

For the three months ended Dec. 31, 2018, OpGen logged $758,959 in revenues compared to $990,912 in the year-ago quarter.

Fourth quarter product sales fell 6 percent to $589,749 from $626,498; laboratory services revenue ticked up 34 percent to $12,510 from $935; and collaboration revenue dropped 57 percent to $156,700 from $363,479.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.

A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.

Broad Institute researchers describe an approach they've dubbed "DNA microscopy."

In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.